Analysts weigh in on Clorox

Estimates on Clorox (CLX -2.6%) are being taken lower by investment firms after the company's FQ4 sales read came in light.

Credit Suisse stays with its Underperform stance, saying Clorox's organic sales will only grow in the low single-digits

B. Riley lowers its FY15 EPS guidance to $4.40, below the mid-point of Clorox's guidance.

Citigroup is taking the long view on Clorox to stick with a Buy rating despite the short-term profit hiccups.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs